BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 21941004)

  • 21. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
    Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
    Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
    Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
    Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
    Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.
    Andrici J; Parkhill TR; Jung J; Wardell KL; Verdonk B; Singh A; Sioson L; Clarkson A; Watson N; Sheen A; Farzin M; Toon CW; Gill AJ
    Pathology; 2016 Jun; 48(4):336-40. PubMed ID: 27114369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
    Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline BAP1 mutations misreported as somatic based on tumor-only testing.
    Abdel-Rahman MH; Rai K; Pilarski R; Davidorf FH; Cebulla CM
    Fam Cancer; 2016 Apr; 15(2):327-30. PubMed ID: 26748926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAP1 mutations in high-grade meningioma: implications for patient care.
    Shankar GM; Santagata S
    Neuro Oncol; 2017 Oct; 19(11):1447-1456. PubMed ID: 28482042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
    Gezgin G; Dogrusöz M; van Essen TH; Kroes WGM; Luyten GPM; van der Velden PA; Walter V; Verdijk RM; van Hall T; van der Burg SH; Jager MJ
    Cancer Immunol Immunother; 2017 Jul; 66(7):903-912. PubMed ID: 28391358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
    Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
    BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.